000			02120nas a22002895i 4500
001			1534-6277
003			DE-He213
005			20200203194442.0
007			cr nn 008mamaa
008			150723s||||||||xxuuu poo|||||| b|EN |d
022			_a1534-6277
024	7		_a10.1007/11864.1534-6277 _2doi
210	1	0	_aCurr. Treat. Options in Oncol.
245	1	0	_aCurrent Treatment Options in Oncology _h[electronic resource] / _cedited by David S. Ettinger.
264		1	_aNew York : _bSpringer US : _bImprint: Springer.
300			_bonline resource.
520			_aThis journal aims to review the most important, recently published treatment option advances in the field of oncology. By providing clear, insightful, balanced contributions by international experts, the journal intends to facilitate worldwide approaches to cancer treatment. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as endocrine tumors, lymphomas, neuro-oncology, and cancers of the breast, head and neck, lung, skin, gastrointestinal tract, and genitourinary region. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. We also provide commentaries from well-known oncologists, and an international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research.  .
650		0	_aOncology.
650	1	4	_aOncology. _0http://scigraph.springernature.com/things/product-market-codes/H33160
700	1		_aEttinger, David S. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
710	2		_aSpringerLink (Online service)
776	0	8	_iPrinted version: _x1527-2729
856	4	0	_uhttps://doi.org/10.1007/11864.1534-6277 _zHybrid
999			_c456861 _d456861
942			_cEMG